The just received September CFIDSLink includes a link to a FAQ about the Lo/Alter study. One answer from Paul Cheney is as follows:
He does not explicitly say that they found XMRV/MLVs in CFS patients, but I cannot think of any reason to call the data "extraordinary" unless they were finding positives in high numbers. This must be one of the rumored positive studies to be presented at the conference.
I have a poster presentation at the International XMRV Workshop on September 7‐8 regarding XMRV/MLV/HGRV detection in my practice done on 47 consecutive patients from October 2009 to December 2009. Those 47 patients are very well characterized including the percentage of overlap diagnoses (FM, MCS, Lyme, IBS, mold‐illness), KPS, age, sex and geographic distribution. The data, I think, are extraordinary, but I cannot talk about it until after the 8th. – Paul R. Cheney, MD, PhD, The Cheney Clinic